SOLUXION Trademark

Trademark Overview

On Friday, May 25, 2018, a trademark application was filed for SOLUXION with the United States Patent and Trademark Office. The USPTO has given the SOLUXION trademark a serial number of 87936099. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 14, 2022. This trademark is owned by Xellia Pharmaceuticals ApS. The SOLUXION trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infective, injectable pharmaceutical products in liquid finished dosage form for use in hospitals and clinics or by home health care professionals
soluxion

General Information

Serial Number87936099
Word MarkSOLUXION
Filing DateFriday, May 25, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 14, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 14, 2019

Trademark Statements

Description of MarkThe mark consists of the word "SOLUXION" in block letters, with a stylized "X" and a droplet "O".
Goods and ServicesAnti-infective, injectable pharmaceutical products in liquid finished dosage form for use in hospitals and clinics or by home health care professionals
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, June 2, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXellia Pharmaceuticals ApS
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCopenhagen S DK2300
DK
Party NameXellia Pharmaceuticals ApS
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCopenhagen S DK2300
DK

Trademark Events

Event DateEvent Description
Monday, February 14, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 14, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, July 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 7, 2021SOU EXTENSION 4 GRANTED
Wednesday, July 7, 2021SOU EXTENSION 4 FILED
Wednesday, July 7, 2021SOU TEAS EXTENSION RECEIVED
Friday, January 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 6, 2021SOU EXTENSION 3 GRANTED
Wednesday, January 6, 2021SOU EXTENSION 3 FILED
Wednesday, January 6, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, June 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 19, 2020SOU EXTENSION 2 GRANTED
Friday, June 19, 2020SOU EXTENSION 2 FILED
Friday, June 19, 2020SOU TEAS EXTENSION RECEIVED
Thursday, December 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 17, 2019SOU EXTENSION 1 GRANTED
Tuesday, December 17, 2019SOU EXTENSION 1 FILED
Tuesday, December 17, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, July 9, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 10, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 10, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 14, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 3, 2019ASSIGNED TO LIE
Thursday, March 14, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 14, 2019ASSIGNED TO EXAMINER
Wednesday, March 13, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 12, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 12, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 12, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 12, 2018NON-FINAL ACTION E-MAILED
Wednesday, September 12, 2018NON-FINAL ACTION WRITTEN
Wednesday, September 5, 2018ASSIGNED TO EXAMINER
Tuesday, June 5, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, June 2, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 29, 2018NEW APPLICATION ENTERED

Related Keywords

soluxion hospitals form clinics health professionals care dosage finished injectable infective